Study guide
13.2 Blood Products & Transfusion Therapy
CRNI® Exam Study Guide Certified Registered Nurse Infusion
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Application & Testing Windows 1.3 Scoring, Results & Recertification
2 Anatomy & Physiology for Infusion Practice
2.1 Vascular Anatomy & Physiology for Infusion 2.2 Body Positioning for Catheter Insertion & Removal 2.3 Vein Selection & Patient Assessment
3 Infection Prevention & Control
3.1 Infection Prevention Strategies & Standard Precautions 3.2 Chain of Infection in Infusion Practice 3.3 Bloodstream Infections & CLABSI Prevention 3.4 Phlebitis: Prevention, Grading & Management
4 Phlebotomy in Infusion Practice
4.1 Blood Sampling & Blood Culture Collection 4.2 Therapeutic Phlebotomy
5 Infusion Equipment & Technology
5.1 Solution Containers, Administration Sets & Filters 5.2 Add-on Devices, Administration Devices & Closed Systems 5.3 Vein Location Devices, Navigation Tools & Securement
6 Peripheral Venous Access Devices
6.1 Short & Long Peripheral Intravenous Catheters 6.2 Midline Catheters 6.3 Peripheral Device Selection Criteria
7 Central Venous Access Devices
7.1 Peripherally Inserted Central Catheters (PICC) 7.2 Non-tunneled Central Venous Catheters 7.3 Tunneled Central Venous Catheters 7.4 Implanted Ports
8 Alternate Access Routes & Device Maintenance
8.1 Subcutaneous Infusion Access 8.2 Intraosseous Access 8.3 Device Maintenance & Care Protocols
9 Special Populations in Infusion Therapy
9.1 Older Adults & Chronic Renal Conditions 9.2 Pediatrics, Immunocompromised, Oncology & Bariatrics
10 Device-Related Complications
10.1 Infiltration & Extravasation 10.2 Catheter Occlusion 10.3 Thrombosis, Air Embolism & Device-Related Systemic Events
11 Fluid & Electrolyte Balance
11.1 Body Composition & Fluid Balance 11.2 Fluid Volume Excess & Deficit 11.3 Electrolyte Disorders 11.4 Maintenance & Replacement Fluids
12 Parenteral Nutrition
12.1 Parenteral Nutrition: Solution Composition 12.2 PN Infectious, Metabolic & Mechanical Complications
13 Anti-infectives, Blood Products & Biologics
13.1 Anti-infective Infusion Therapy 13.2 Blood Products & Transfusion Therapy 13.3 Biologics & Immunologic Therapies
14 Antineoplastic, Cardiovascular & Pain Infusions
14.1 Antineoplastic Infusion Therapy 14.2 Cardiovascular Infusions 14.3 Pain Management Infusions
15 Therapy-Related Complications & Hazardous Drugs
15.1 Rate-Related Complications 15.2 Adverse Drug Reactions 15.3 Hazardous Drug Exposure & Waste Disposal
16 Professional Practice, Documentation & Quality
16.1 Assessment, Consent & Collaborative Care Planning 16.2 Documentation, Laws & Regulatory Agencies 16.3 Evidence-Based Practice & Performance Improvement
13.2 Blood Products & Transfusion Therapy
Key Takeaways Explain This Topic AI
ABO and Rh compatibility rules protect against acute hemolytic reactions: type & screen establishes blood type and antibodies; crossmatch verifies donor unit compatibility before RBC transfusion when required.
Match product to need: packed RBCs for oxygen-carrying capacity, platelets for thrombocytopenia/bleeding risk, FFP for coagulation factor replacement, and cryoprecipitate for fibrinogen (and selected factor) support at a high level.
Two-nurse independent verification of patient identity and product labels is mandatory; infuse RBCs typically within 4 hours of issue/start per standards; use 0.9% sodium chloride only with blood—not LR or dextrose solutions as the co-infusion fluid.
For suspected transfusion reactions, STOP the transfusion, keep the IV line open with normal saline (new tubing per protocol), assess ABCs/vitals, notify provider and blood bank, and return product/tubing as required.
Differentiate reaction patterns: acute hemolytic, febrile non-hemolytic, allergic/anaphylactic, TRALI, and TACO—recognition drives whether the problem is immune hemolysis, fluid overload, or pulmonary injury.
Last updated: August 2026
Transfusion therapy on the CRNI blueprint
Domain 3F Blood and Blood Component Therapy tests whether you can select, verify, administer, and rescue blood products like an infusion specialist. Errors in identification or reaction response are among the highest-harm events in nursing—CRNI expects disciplined process, not casual “hang and hope.”
Quick Answer: Know ABO/Rh , type & screen vs crossmatch , product roles ( PRBCs, platelets, FFP, cryo ), 2-nurse check , RBC ≤ ~4 hours , NS only with blood, and for reactions: STOP , keep line open with NS , notify provider/blood bank. Distinguish acute hemolytic, FNHTR, allergic/anaphylactic, TRALI, TACO .
- ABO and Rh compatibility principles
- ABO system (concept level)
Red cells carry A and/or B antigens ; plasma contains the opposite isohemagglutinins (antibodies). Incompatible RBC transfusion can trigger acute intravascular hemolysis —a sentinel-event pattern.
- Recipient type Can typically receive RBCs from Plasma considerations (high level)
- O O O is universal RBC donor; O plasma is not universal
- A A, O
- B B, O
- AB AB, A, B, O AB often considered universal plasma donor conceptually
Rh (D): Rh-negative patients, especially women of childbearing potential, should avoid unnecessary Rh-positive RBC exposure when Rh-negative units are available, to prevent alloimmunization. Emergency uncrossmatched O-negative (or institutional emergency O strategy) may be used in life-threatening bleeding per protocol—still document and transition to type-specific products ASAP.
Type & screen vs crossmatch
Test What it does When it matters
Type & screen Determines ABO/Rh and screens for unexpected red-cell antibodies Baseline for possible transfusion; may support electronic crossmatch pathways when screen is negative
Crossmatch Serologic or electronic compatibility check between patient and specific donor unit Required pathway before many RBC transfusions, especially with antibodies or per blood bank rules
Nursing role: draw correctly labeled specimens (two-identifier rules, no drawing from a line that contaminates the type), send promptly, and never hang a unit that does not match the patient’s identifiers and blood bank release documentation .
Exam trap: Relying on “I know this patient” memory instead of formal identification against the product tag.
Major blood products and high-level indications
Product Primary purpose High-level indication themes
Packed RBCs (PRBCs) Increase oxygen-carrying capacity Symptomatic anemia, acute blood loss with impaired oxygen delivery—not automatic transfusion for every low number without clinical context
Platelets Support primary hemostasis Thrombocytopenia with bleeding or high procedural/bleeding risk per thresholds
Fresh frozen plasma (FFP) Replace multiple coagulation factors Coagulopathy with bleeding or invasive procedure need; massive transfusion protocols; selected factor deficiencies when concentrates unavailable
Cryoprecipitate Concentrated fibrinogen (also factors VIII, XIII, vWF in classic teaching) Hypofibrinogenemia, selected bleeding scenarios, some obstetric hemorrhage protocols
Additional products (albumin, plasma derivatives, granulocytes, factor concentrates) appear in specialty practice; know that albumin is not a substitute for PRBCs for oxygen delivery and that volume expanders ≠ clotting factor replacement .
- Pretransfusion verification and administration rules
- Two-nurse check
Two qualified clinicians independently verify at the bedside:
- Patient identity (name, unique identifiers—ask patient to state name/DOB when able)
- ABO/Rh and unit number match between product label, transfusion record, and patient blood bank band/record
- Expiration date/time and product appearance (clots, discoloration, leaks—do not hang compromised units)
- Special requirements (CMV-safe, irradiated, washed, antigen-negative) when ordered
Remain with the patient for the initial monitoring period (commonly the first 15 minutes) and recheck vitals per policy. Baseline vitals before start are mandatory for later reaction comparison.
Infusion time limits and equipment
RBCs: complete typically within 4 hours of removal from controlled storage/start per standards—bacteria can proliferate in warm blood.
Platelets and plasma have their own handling/time rules—follow blood bank labeling; do not store platelets in a medication refrigerator against policy.
Use a blood administration set with an appropriate filter (standard 170–260 micron clot filter themes).
0.9% sodium chloride (NS) is the standard compatible fluid with blood components.
Do not co-infuse blood with lactated Ringer’s (calcium can promote clotting in the set) or dextrose-containing solutions (can cause hemolysis/clumping themes) as the Y-site fluid.
Do not add medications to the blood bag. No IV push drugs into the blood tubing while the unit is running unless policy creates a separate lumen plan.
Warmers and pressure devices only as ordered/indicated—unmonitored microwave or hot-water warming is forbidden.
- Exam trap: Piggybacking blood with D5NS or LR “because that’s what was hanging.”
- Transfusion reactions: recognize, stop, support
- Universal first response
For any suspected acute transfusion reaction:
STOP the transfusion immediately.
Maintain IV access; keep the line open with normal saline —typically with new tubing so residual blood in the set does not continue into the patient (follow exact facility steps).
Assess ABCs , mental status, vitals, urine color, pain, dyspnea, rash.
Notify the provider and blood bank promptly.
Recheck clerical identification at the bedside (wrong unit to wrong patient is a classic cause of hemolytic reaction).
Send remaining product, tubing, and required labs/urine per protocol; document meticulously.
Do not restart the same unit after a significant reaction without explicit blood bank/provider direction.
Reaction patterns (high-yield differentiation)
Reaction Typical clues Nursing implications
Acute hemolytic (AHTR) Fever, flank/back/chest pain, hemoglobinuria, hypotension, anxiety, DIC/bleeding—often within minutes; ABO mismatch classic Stop immediately; aggressive support; medical emergency; prevent further incompatible product
Febrile non-hemolytic (FNHTR) Fever/chills without hemolysis evidence; cytokine/leukocyte related Stop and evaluate to exclude hemolysis; antipyretics as ordered; leukocyte-reduced products reduce risk
Allergic Urticaria, pruritus, mild rash Stop/assess; antihistamines as ordered; mild isolated urticaria may allow cautious restart of same unit only if protocol and provider allow after treatment—many facilities require full workup first
Anaphylactic Bronchospasm, angioedema, hypotension, shock—IgA deficiency theme sometimes cited Stop; epinephrine and emergency protocol; never minimize airway symptoms
TRALI (transfusion-related acute lung injury) Acute respiratory distress, hypoxemia, non-cardiogenic pulmonary edema during/within hours of transfusion Stop; oxygen/ventilatory support; report as serious reaction; distinguish from TACO
TACO (transfusion-associated circulatory overload) Dyspnea, hypertension, tachycardia, elevated JVP, positive fluid balance—cardiogenic overload pattern Stop/slow future strategy; upright position, oxygen, diuretics as ordered; rate and volume planning for at-risk patients
TRALI vs TACO is a frequent exam discriminator: both cause respiratory distress after transfusion, but TACO looks like volume overload/heart failure (hypertension, response to diuretics), while TRALI is permeability/non-cardiogenic edema (often fever, hypotension or normal BP themes, not simply “too much fluid”). Exact labs (BNP, chest x-ray, echo) are ordered by the team; nursing contribution is early recognition, stop, support, and accurate description.
Delayed reactions (delayed hemolytic, TA-GVHD in rare settings) exist but acute bedside recognition of the table above drives most CRNI items.
Special administration considerations
Massive transfusion: follow institutional MTP ratios, warmer use, electrolyte monitoring (citrate-related hypocalcemia, hyperkalemia themes), and communication with blood bank.
Jehovah’s Witness / refusal: respect informed refusal; document; offer alternatives per ethics/policy—never coerce.
Religious/cultural and consent: verify consent is complete before elective transfusion.
Pediatric and elderly: weight-based volumes, slower rates, higher TACO sensitivity in frail elders and cardiac patients—split units or slower rates as ordered.
Autologous vs allogeneic: same verification rigor; autologous is not risk-free (bacterial contamination, clerical error still possible).
Scenarios
Scenario A — Wrong fluid: Blood arrives; only LR is hanging. Spike a new NS primary for the blood set; do not Y-site blood into LR.
Scenario B — Mid-unit fever and back pain: Stop transfusion, NS keep-open, vitals, notify, clerical recheck—treat as possible acute hemolytic until proven otherwise.
Scenario C — Hypertensive crackles after two RBC units: Think TACO ; stop, sit upright, oxygen, notify for diuretic orders; plan slower future transfusions.
Scenario D — Identity: Unit label DOB differs by one digit from wristband. Do not hang—return to blood bank and resolve discrepancy.
- High-yield exam traps (blood products)
- Skipping two-nurse verification or hanging despite identifier mismatch
- Completing RBCs over >4 hours
- Using LR or D5 with blood
- Treating reaction by “slowing a little” without stopping when hemolysis or severe symptoms are possible
- Confusing TACO (overload) with TRALI (lung injury)
- Transfusing PRBCs for volume expansion alone when crystalloid/colloid strategy is intended
- Drawing type-and-screen from a contaminated line or mislabeled tube
- Restarting a unit after anaphylaxis or clear hemolytic signs without blood bank clearance